American Medical Systems
14
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
7.1%
1 terminated/withdrawn out of 14 trials
91.7%
+5.2% vs industry average
36%
5 trials in Phase 3/4
73%
8 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Sacrocolpopexy Versus Vaginal Mesh Procedure for Pelvic Prolapse
Role: collaborator
Evaluation of the 2005 AMS (American Medical System) IPP (Inflatable Penile Prosthesis)
Role: lead
Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia
Role: collaborator
Performance Evaluation of the AMS CONTINUUM™ Device
Role: lead
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Role: lead
Global Performance Evaluation of the AMS CONTINUUM™ Device
Role: lead
A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization
Role: lead
AMS AdVance and AdVance XP Male Sling Systems for the Treatment of Stress Urinary Incontinence Following Prostatectomy: Evaluation of Safety, Efficacy, and Quality of Life Through Retrospective Chart Review and Prospective Follow-up
Role: lead
The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy
Role: collaborator
JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers
Role: lead
TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management
Role: collaborator
Study Comparing Tension-free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence
Role: collaborator
MiniArc Study: Long-Term Effectiveness Trial for AMS Sling Systems
Role: lead
Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
Role: lead
All 14 trials loaded